Ewing’s sarcoma family of tumors in Finland during 1990–2009: A population-based study

References

• De Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000;18:204–13.
   PubMed Web of Science ®Google Scholar
• Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 2000;82:667–74.
   PubMed Web of Science ®Google Scholar
• Weber KL. Current concepts in the treatment of Ewing’s sarcoma. Expert Rev Anticancer Therapy 2002;2:687–94.
   PubMedGoogle Scholar
• Perouli E, Chrysikopoulos H, Vlachos A, Koskinas A, Batistatou A, Polyzoidis K. Imaging findings in paraspinal extra osseous Ewing sarcoma. JBR-BTR 2006;89:310–2.
   PubMedGoogle Scholar
• Jawad MU, Haleem AA, Scully SP. Malignant sarcoma of the pelvic bones: Treatment outcomes and prognostic factors vary by histopathology. Cancer 2011;117:1529–41.
   PubMed Web of Science ®Google Scholar
• Bacci G, Boriani S, Balladelli A, Barbieri E, Longhi A, Alberghini M, et al. Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: The experience from a single institution. Eur Spine J 2009;18:1091–5.
   PubMed Web of Science ®Google Scholar
• Bacci G, Longhi A, Ferrari S, Mercuri M, Versari M, Bertoni F. Prognostic factors in non-metastatic Ewing’s sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006:45:469–75.
   PubMed Web of Science ®Google Scholar
• Schuck A, Ahrens S, Paulussen M, Kuhlen M, Konemann S, Rube C, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003;55:168–77.
   PubMed Web of Science ®Google Scholar
• Eyre R, Feltbower RG, Mubwandarikwa E, Jenkinson HC, Parkes S, Birch JM, et al. Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981– 2002. Br J Cancer 2009; 100:188–93.
   Web of Science ®Google Scholar
• Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, et al. Prognostic factors in Ewing’s tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 2000;18:3108–14.
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ. Survival of patients with malignant primary osseous spinal neoplasms: Results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. J Neurosurg Spine 2011;14:143–50.
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. New Engl J Med 2003; 348:694–701.
   PubMed Web of Science ®Google Scholar
• Elomaa I, Blomqvist CP, Saeter G, Akerman M, Stenwig E, Wiebe T, et al. Five-year results in Ewing’s sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Eur J Cancer 2000;36:875–80.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, et al. Nonmetastatic Ewing family tumors: High-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol 2011;22:1221–7.
   PubMed Web of Science ®Google Scholar
• Smeland S, Wiebe T, Brosjö O, Böhling T, Alvegård TA. Chemotherapy in Ewing’s sarcoma. Acta Orthop Scand 2004;75:87–91.
   Web of Science ®Google Scholar
• Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365–9.
   PubMed Web of Science ®Google Scholar
• Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010;116:1964–73.
   PubMed Web of Science ®Google Scholar
• Pradhan A, Grimer RJ, Spooner D, Peake D, Carter SR, Tillman RM, et al. Oncological outcomes of patients with Ewing’s sarcoma: Is there a difference between skeletal and extra-skeletal Ewing’s sarcoma? J Bone Joint Surg Br 2011; 93:531–6.
   PubMedGoogle Scholar
• Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, et al. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011; 117:3027–32.
   PubMed Web of Science ®Google Scholar
• Picci P, Bohling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing’s sarcoma of the extremities. J Clin Oncol 1997;15:1553–9.
   PubMed Web of Science ®Google Scholar
• Huvos A, editor. Bone tumors: Diagnosis, treatment and prognosis. 2nd ed. Philadelphia: WB Saunders; 1991.
   Google Scholar
• Bohling T, Bacchini P, Bertoni F, Bjerkehagen B, Domanski H, Kindblom LG, et al. Diagnosis and tumor response in osteosarcoma and Ewing’s sarcoma. Acta Orthop Scand Suppl 2004;75:72–6.
   PubMedGoogle Scholar
• McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing’s sarcoma family of tumours. Ann Oncol 2006;17:1301–5.
   PubMed Web of Science ®Google Scholar
• Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not improve prognosis. J Clin Oncol 2001;19:2812–20.
   PubMed Web of Science ®Google Scholar
• Ladenstein R, Potschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: Results of the Euro-EWING 99 trial. J Clin Oncol 2010;28:3284–91.
   PubMed Web of Science ®Google Scholar
• Bacci G, Longhi A, Ferrari S, Mercuri M, Barbieri E, Bertoni F, et al. Pattern of relapse in 290 patients with nonmetastatic Ewing’s sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. Eur J Surg Oncol 2006; 32:974–9.
   Web of Science ®Google Scholar
• Barker LM, Pendergrass TW, Sanders JE, Hawkins DS. Survival after recurrence of Ewing’s sarcoma family of tumors. J Clin Oncol 2005;23:4354–62.
   PubMed Web of Science ®Google Scholar